Global Recombinant Therapeutic Antibodies and Proteins Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specifically targeted therapeutic process by compensating the deficiency of an essential protein. Recombinant proteins have gained significant traction for therapeutic applications and the number of proteins either launched or approved into clinical trials has continually increased over the past two decades. According to the National Center for Biotechnology Information (NCBI) data of 2017, the U.S. Food and Drug Administration (FDA) approved over 140 recombinant therapeutic proteins for human use and several hundred are currently in development. Majority of these proteins are recombinant monoclonal antibodies.
Scope of the Report:
This report focuses on the Recombinant Therapeutic Antibodies and Proteins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global recombinant therapeutic antibodies and proteins market size was valued at US$ 92.5 billion in 2017, and is expected to witness a robust CAGR of 11.2% over the forecast period (2017 – 2025).
The worldwide market for Recombinant Therapeutic Antibodies and Proteins is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Recombinant Therapeutic Antibodies and Proteins Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Recombinant Therapeutic Antibodies and Proteins, with sales, revenue, and price of Recombinant Therapeutic Antibodies and Proteins, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Recombinant Therapeutic Antibodies and Proteins, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Recombinant Therapeutic Antibodies and Proteins market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Recombinant Therapeutic Antibodies and Proteins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the Recombinant Therapeutic Antibodies and Proteins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global recombinant therapeutic antibodies and proteins market size was valued at US$ 92.5 billion in 2017, and is expected to witness a robust CAGR of 11.2% over the forecast period (2017 – 2025).
The worldwide market for Recombinant Therapeutic Antibodies and Proteins is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Abbott
- Amgen
- Biogen
- Eli Lilly
- Roche
- Johnson and Johnson
- Merck
- Novo Nordisk
- Pfizer
- Sanofi
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Plasma Protein
- Fusion Proteins
- Monoclonal Antibodies
- Hormones
- Enzyme
- Coagulation Factors
- Others
- Oncology
- Hematology
- Immunology
- Endocrinology
- Infectious Disease
- Cardiovascular Disease
- Others
Chapter 1, to describe Recombinant Therapeutic Antibodies and Proteins Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Recombinant Therapeutic Antibodies and Proteins, with sales, revenue, and price of Recombinant Therapeutic Antibodies and Proteins, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Recombinant Therapeutic Antibodies and Proteins, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Recombinant Therapeutic Antibodies and Proteins market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Recombinant Therapeutic Antibodies and Proteins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Recombinant Therapeutic Antibodies and Proteins Introduction
1.2 Market Analysis by Type
1.2.1 Plasma Protein
1.2.2 Fusion Proteins
1.2.3 Monoclonal Antibodies
1.2.4 Hormones
1.2.5 Enzyme
1.2.6 Coagulation Factors
1.2.7 Others
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Hematology
1.3.3 Immunology
1.3.4 Endocrinology
1.3.5 Infectious Disease
1.3.6 Cardiovascular Disease
1.3.7 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Abbott
2.1.1 Business Overview
2.1.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biogen
2.3.1 Business Overview
2.3.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biogen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche
2.5.1 Business Overview
2.5.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson and Johnson
2.6.1 Business Overview
2.6.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novo Nordisk
2.8.1 Business Overview
2.8.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Therapeutic Antibodies and Proteins Manufacturer Market Share in 2017
3.3.2 Top 6 Recombinant Therapeutic Antibodies and Proteins Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS MARKET ANALYSIS BY REGIONS
4.1 Global Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Regions (2013-2018)
4.1.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Regions (2013-2018)
4.2 North America Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
4.3 Europe Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
4.5 South America Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
5 NORTH AMERICA RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS BY COUNTRIES
5.1 North America Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries
5.1.1 North America Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)
5.1.2 North America Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)
5.2 United States Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
5.3 Canada Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
5.4 Mexico Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
6 EUROPE RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS BY COUNTRIES
6.1 Europe Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries
6.1.1 Europe Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)
6.2 Germany Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
6.3 UK Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
6.4 France Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
6.5 Russia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
6.6 Italy Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS BY COUNTRIES
7.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)
7.2 China Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
7.3 Japan Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
7.4 Korea Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
7.5 India Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS BY COUNTRIES
8.1 South America Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries
8.1.1 South America Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)
8.1.2 South America Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
8.3 Argentina Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
8.4 Colombia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS BY COUNTRIES
9.1 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
9.3 UAE Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
9.4 Egypt Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
9.5 Nigeria Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
9.6 South Africa Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
10 GLOBAL RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS MARKET SEGMENT BY TYPE
10.1 Global Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Type (2013-2018)
10.1.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Type (2013-2018)
10.2 Plasma Protein Sales Growth and Price
10.2.1 Global Plasma Protein Sales Growth (2013-2018)
10.2.2 Global Plasma Protein Price (2013-2018)
10.3 Fusion Proteins Sales Growth and Price
10.3.1 Global Fusion Proteins Sales Growth (2013-2018)
10.3.2 Global Fusion Proteins Price (2013-2018)
10.4 Monoclonal Antibodies Sales Growth and Price
10.4.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
10.4.2 Global Monoclonal Antibodies Price (2013-2018)
10.5 Hormones Sales Growth and Price
10.5.1 Global Hormones Sales Growth (2013-2018)
10.5.2 Global Hormones Price (2013-2018)
10.6 Enzyme Sales Growth and Price
10.6.1 Global Enzyme Sales Growth (2013-2018)
10.6.2 Global Enzyme Price (2013-2018)
10.7 Coagulation Factors Sales Growth and Price
10.7.1 Global Coagulation Factors Sales Growth (2013-2018)
10.7.2 Global Coagulation Factors Price (2013-2018)
10.8 Others Sales Growth and Price
10.8.1 Global Others Sales Growth (2013-2018)
10.8.2 Global Others Price (2013-2018)
11 GLOBAL RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS MARKET SEGMENT BY APPLICATION
11.1 Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Hematology Sales Growth (2013-2018)
11.4 Immunology Sales Growth (2013-2018)
11.5 Endocrinology Sales Growth (2013-2018)
11.6 Infectious Disease Sales Growth (2013-2018)
11.7 Cardiovascular Disease Sales Growth (2013-2018)
11.8 Others Sales Growth (2013-2018)
12 RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS MARKET FORECAST (2018-2023)
12.1 Global Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Growth Rate (2018-2023)
12.2 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Regions (2018-2023)
12.2.1 North America Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)
12.2.2 Europe Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)
12.2.3 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)
12.2.4 South America Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)
12.2.5 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)
12.3 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Type (2018-2023)
12.3.1 Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Type (2018-2023)
12.3.2 Global Recombinant Therapeutic Antibodies and Proteins Market Share Forecast by Type (2018-2023)
12.4 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Application (2018-2023)
12.4.1 Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Application (2018-2023)
12.4.2 Global Recombinant Therapeutic Antibodies and Proteins Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Recombinant Therapeutic Antibodies and Proteins Introduction
1.2 Market Analysis by Type
1.2.1 Plasma Protein
1.2.2 Fusion Proteins
1.2.3 Monoclonal Antibodies
1.2.4 Hormones
1.2.5 Enzyme
1.2.6 Coagulation Factors
1.2.7 Others
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Hematology
1.3.3 Immunology
1.3.4 Endocrinology
1.3.5 Infectious Disease
1.3.6 Cardiovascular Disease
1.3.7 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Abbott
2.1.1 Business Overview
2.1.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biogen
2.3.1 Business Overview
2.3.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biogen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche
2.5.1 Business Overview
2.5.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson and Johnson
2.6.1 Business Overview
2.6.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novo Nordisk
2.8.1 Business Overview
2.8.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Recombinant Therapeutic Antibodies and Proteins Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Recombinant Therapeutic Antibodies and Proteins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Therapeutic Antibodies and Proteins Manufacturer Market Share in 2017
3.3.2 Top 6 Recombinant Therapeutic Antibodies and Proteins Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS MARKET ANALYSIS BY REGIONS
4.1 Global Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Regions (2013-2018)
4.1.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Regions (2013-2018)
4.2 North America Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
4.3 Europe Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
4.5 South America Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
5 NORTH AMERICA RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS BY COUNTRIES
5.1 North America Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries
5.1.1 North America Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)
5.1.2 North America Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)
5.2 United States Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
5.3 Canada Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
5.4 Mexico Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
6 EUROPE RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS BY COUNTRIES
6.1 Europe Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries
6.1.1 Europe Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)
6.2 Germany Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
6.3 UK Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
6.4 France Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
6.5 Russia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
6.6 Italy Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS BY COUNTRIES
7.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)
7.2 China Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
7.3 Japan Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
7.4 Korea Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
7.5 India Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS BY COUNTRIES
8.1 South America Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries
8.1.1 South America Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)
8.1.2 South America Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
8.3 Argentina Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
8.4 Colombia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS BY COUNTRIES
9.1 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
9.3 UAE Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
9.4 Egypt Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
9.5 Nigeria Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
9.6 South Africa Recombinant Therapeutic Antibodies and Proteins Sales and Growth Rate (2013-2018)
10 GLOBAL RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS MARKET SEGMENT BY TYPE
10.1 Global Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Recombinant Therapeutic Antibodies and Proteins Sales and Market Share by Type (2013-2018)
10.1.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Type (2013-2018)
10.2 Plasma Protein Sales Growth and Price
10.2.1 Global Plasma Protein Sales Growth (2013-2018)
10.2.2 Global Plasma Protein Price (2013-2018)
10.3 Fusion Proteins Sales Growth and Price
10.3.1 Global Fusion Proteins Sales Growth (2013-2018)
10.3.2 Global Fusion Proteins Price (2013-2018)
10.4 Monoclonal Antibodies Sales Growth and Price
10.4.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
10.4.2 Global Monoclonal Antibodies Price (2013-2018)
10.5 Hormones Sales Growth and Price
10.5.1 Global Hormones Sales Growth (2013-2018)
10.5.2 Global Hormones Price (2013-2018)
10.6 Enzyme Sales Growth and Price
10.6.1 Global Enzyme Sales Growth (2013-2018)
10.6.2 Global Enzyme Price (2013-2018)
10.7 Coagulation Factors Sales Growth and Price
10.7.1 Global Coagulation Factors Sales Growth (2013-2018)
10.7.2 Global Coagulation Factors Price (2013-2018)
10.8 Others Sales Growth and Price
10.8.1 Global Others Sales Growth (2013-2018)
10.8.2 Global Others Price (2013-2018)
11 GLOBAL RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS MARKET SEGMENT BY APPLICATION
11.1 Global Recombinant Therapeutic Antibodies and Proteins Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Hematology Sales Growth (2013-2018)
11.4 Immunology Sales Growth (2013-2018)
11.5 Endocrinology Sales Growth (2013-2018)
11.6 Infectious Disease Sales Growth (2013-2018)
11.7 Cardiovascular Disease Sales Growth (2013-2018)
11.8 Others Sales Growth (2013-2018)
12 RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS MARKET FORECAST (2018-2023)
12.1 Global Recombinant Therapeutic Antibodies and Proteins Sales, Revenue and Growth Rate (2018-2023)
12.2 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Regions (2018-2023)
12.2.1 North America Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)
12.2.2 Europe Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)
12.2.3 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)
12.2.4 South America Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)
12.2.5 Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Forecast (2018-2023)
12.3 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Type (2018-2023)
12.3.1 Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Type (2018-2023)
12.3.2 Global Recombinant Therapeutic Antibodies and Proteins Market Share Forecast by Type (2018-2023)
12.4 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Application (2018-2023)
12.4.1 Global Recombinant Therapeutic Antibodies and Proteins Sales Forecast by Application (2018-2023)
12.4.2 Global Recombinant Therapeutic Antibodies and Proteins Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Recombinant Therapeutic Antibodies and Proteins Picture
Table Product Specifications of Recombinant Therapeutic Antibodies and Proteins
Figure Global Sales Market Share of Recombinant Thera
Figure Recombinant Therapeutic Antibodies and Proteins Picture
Table Product Specifications of Recombinant Therapeutic Antibodies and Proteins
Figure Global Sales Market Share of Recombinant Thera
